ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,515, issued on Aug. 4, was assigned to Beijing University of Chemical Technology (Beijing).
"Genetically engineered bacterium using glucose as substrate for de novo synthesis of vanillin and application thereof" was invented by Tianwei Tan (Beijing), Yingyue Yu (Beijing), Haowen Zhu (Beijing) and Jianyu Long (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a genetically engineered bacterium using glucose as a substrate for de novo synthesis of vanillin and an application thereof, which belongs to the technical field of gene recombination and metabolic engineering. The genetically engineered bacterium using the g...